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Synopsis 
The glyco~roteln hormone family comprising of Luteinizlng Hormone (LH). 
Chononlc Gonadotropin (hCG), Foll~cle Stimulatrng Hormone (FsH) and ~ h , ~ ~ ~ d  
stlmulatlng Hormone (TSH) plays important role In reproduction and overall physrology 
of the organism These hormones are heterodimenc molecules consisting of an ]dentlcal 
a subunit non-covalently associated w t h  the hormone-specific P subunlt Both subunits 
of all these hormones are N-glycosylated In addition, hCG@ subunit also has four O- 
linked ol~gosacchmdes located at the C-termmus of the pobpeptide(1) The u and P 
subunrts of all these hormones contatn five and six disulfide bonds respecti~ely and the 
crystal structures ofhCG and hFSH indicate that both subunits ofthe hormones belong to 
the cystine knot family of protems(2-4) Although the 8 subunits are hormone specific, 
there are distlnct simllmhes in these subunits wth  the 12 cystetnes consened In all these 
subunits (1). These hormones, because oftheir unique structural features habe proled to 
be Important models for structure-finchon relationship studies of complex dimeric 
glycoprotems. Foldlng of subunits dunng biosynthesis, role of glycosylatlon In folding 
pathways and zn vztro and zn vlvo broactivlty of the hormone, as well as, rdentificat~on of 
domans important for subunit association, receptor bindlng and subsequent signal 
transduction have been topics of active invesfigatlons 
The receptors of these hormones belong to the famlly of G-protein coupled receptors 
(GPCR) and have unique hormone specific exodoman not present in other members of 
the GPCR fitmily and charactenstic seven transmembrane domarns followed by a C 
termlnal doman(5) Pnmary structure analysis of Glycoprotein hormone receptors family 
revealed sequence conservation, maxlmum homology belng observed m the 
transmembrane doman (TMD)(6) Significant homologies could be observed In the 
hormone specific extracellular domatns (ECD) also (7) Despite these homologtes, the 
receptors exhibit exquisite specificity with very low cross reactlvtty with other members 
of the hormone h l l y  (8) 
Elucidation of the molecular detalls of the contacts between the hormone and the 
receptors has not been achieved so far. Various approaches have been employed to 
delineate the residues or domains of both hormone and receptors involved m interaction 
These include test~ng of chlmeras or mutants of hormones or receptors for changes in 
activity (9-12), chem~cal modifications(l3) and competition with peptides from either 
hormones (14) or receptors(l5). Polyclonal and monoclonal anbbodles agamst 
glycoprotein hormones and various Merits of their receptors have been used to 
determine the role of different domans of both m binding and response (6, 16, 17) 
However, till date there IS no consensus on the spec~fic mechanisms by whlch the 
glycoprotern hormone docks onto its receptor It was proposed that the lnltlal contact 
between the hormone and the receptor occurs through high affinlty b~nding of the 
hormone specific P subunit to the Leucine rich regions of the ECD that results in 
conformational changes in both hormone, as well as, the receptor and bnngs 
hormonelECD complex closer to the TMD of the receptor. The secondary, relatively 
lower affinity interactions between the hormone and the receptor then take place through 
common a subunit and exoloops of TMD of the receptor resulting in signal generation 
(1 8, 19). Recently a different kind of model has been proposed which suggests that the 
hormone does not make any direct contacts with the TMD of the receptor. The signal is 
transduced the change In contacts between ECD and TMD brought about b) 
hormone's interact~on with ECD(8,20) 
The present study was lnlfiated ~ 7 t h  an overall ob~ect t~e of understanding the 
n ~ ~ l ~ c u l a r  details of the hormone receptor lnteract~ons of this kmlly. pmlcularl? ~ C G -  
LH receptor lnteractlons Two different approaches were emploqed for this purpose; the 
first, direct approach being structure elucidation of the members of the glbcoproteln 
hormone famll~ while the second approach uses ant~bodles agalnst hCG as tools to probe 
Into hormone-receptor lnteractlons The results obtalned uslng these t1i.o approaches hake 
been consolidated in the present thesls and are organized as fo l lo~s  
Chapter 1 1s an extensive revlew of the literature and lt bullds background for the present 
work whlle the exact a m  and scope of the present work have been defined In Chapter 2 
Chapter 3 descnbes clomng, expression and punficatlon of recomblnant glqcoproteln 
hormones hLH, hCG and single chain denvatwe of hCG The Chapter 4 glves details of 
the molecular aspects of hCG-LH receptor interaction dissected us~ng hCG monoclonal 
anhbodles (MAbs) Chapter 5 discusses ~mpl~cat~ons f the observat~ons made In the 
present study and states the future direcfions envisaged 
There are a number of endocnnopahes associated with abnormal levels of 
glycoprotein hormones and treatments of such disorders offen demand large quantit~es of 
elther agonlsts or antagonists of the hormones The structure-hcbon relat~onshlp studles 
should help In ~dent~fy~ng domiuns/residues important for subun~t ~nteractlon. receptor 
blndmg, and signal transducbon, which would also allow engneering of agonlsts and 
antagonists of hormone action. However, structure determ~nation of the glycoprote~n 
honnone fam~ly usmg X-ray crystallography has proved to be a difficult task and zt IS 
belleved that the heterogeneity in glycosylafion 1s the pnmary reason for thls low success 
rate in the process of crystallivlt~on The first crystal structure of hCG was that of 
completely deglycosylated hCG but such a molecule displays antagonisfic behavlor(2,3) 
Use of NMR spectroscopy, the alternate method commonly used for structure 
determlnatlon 1s often lunrted by the avsllab~hty of large quantities of biologrcally actlve 
hormones h e  of any contarmnants Large quantities of LH, hCG and FSH are also 
requ~red for treatment of inbrtile patients suffering from gonadotropin deficiency The 
first goal of the present study was thus to produce and pun& biologically act~ve 
recomblnant hCG and hLH. Owmg to the inherent features of glycoprotein hormones and 
their potential therapeutic apphcations, the recombinant expression of these hormones IS 
an important goal f h r n  both basic research, as well as, commercial potnt of view. 
Consldenng the above mentioned features it 1s clear that the expression system used far 
the hyperexpression of these glycopmteln hormones should also serve as a model system 
for investigating structurefunction relationships and folding of subunits during 
biosynthesis, in addltion to providing sufficient quantities of the hormones for ctlnicat 
applications. It has been demonstrated that N-Wed glycosylation during blosynthesls 
fiicil~tates protetn fold~ng and conformational maturation of glycoproteln honnone 
subun~ts into an assembly-competenf biologically active form (21). Therefore, the ideal 
recombinant expression system should also be able to glycosylate the ~mtein during 
blosynthesls The Pzchla pastorls yeast expression system was chosen for 
hyperexpression of glycopmteln hormones as it blends the advantapes of bath bac*nal 
and m-allm expression systems. Earlier, expression of biologically active hCG and 
the subunits of hCG and bovine FSH using Pichia pasloris expression system has been 
=ported from the laboratory (22, 23) Chapter 3 (section 3 3 I )  of the thesis describes 
h ~ ~ e r e x ~ r e s s l o n  of hLH. The expression of these heterologous pmtems scaled up 
using fermentation procedures to hlfill the requirements of large quantlhes ofhormones 
for various a ~ ~ h c a h o n s  Punficatlon of Pichia expressed hormones turned out to be a 
complex task as large quantity of the hormone was secreted out In the fementatron 
medium (IOhtre volume) that Was of hlgh ionlc strength Of several &&rent strateges 
attempted for concentrahon and partla1 punficatron of recomb~nant hCG, hqdmphobrc 
interaction chromatography (HIC) uslng Phenyl Sepharose matnx emerged as the most 
efficient technique as a first step of purification. Subsequently. cation exchange 
chromatography using SP- Sepharose matrix yielded completely purified biologically 
achve recombinant hCG (section 3 3 2) The preliminarj data also suggested that Plchla 
cells express a biolog~cally active form of hCG whlch appeared to be less glycos>lated 
and of lower molecular weight Using the same protocol pwficatron of hLH, as well as, 
single cham denvahve of hCG, phCGaP was achteked (section 3 33) These 
recombinant proteins were charactenzed extensively using various brochernical, as uell 
as, immunologgcal critena and were shown to be s~rnllar to theu natural counterparts with 
respect to their ability to bind LH receptor and to transduce signal as judged by 
radioreceptorassays and m vltro bioassays respectively The hjdrophob~c mteractlon 
chromatography proved an important starting pant for punficatlon of all the other 
members of the glycoprotein hormone family expressed uslng Achmpastor~s expression 
system 
With the avrulability of punfied, biologtcally active recombinant hCG In large 
quantihes ~t was now poss~ble to make attempts towards structun: elucidatron using NMR 
spectroscopy The structure detennmation of such complex protelns by NMR 
spectroscopy is made relatively easier by labeling the roteins wth magnetically more 
acbve, stable lsotopes of carbon and nitrogen, I3c and '6 respec~vely however the cost 
IS often prohib~hvely h~gh  The Ach~apastorzs expression system o&rs simple means of 
labeling the protetns as the cells can be grown on simple salts of carbon and nitrogen 
such as I3c labeled methanol, I%! labeled ammomum chlonde or ammonium sulphate. 
The Chapter 3 also ggves a brief account of the preliminary attempts made to label the 
recombinant hCG with '%I and the structural studies canid out with the carbohydrate 
moleties of the recombinant hCG ustng solution NMR spectmscopy. This work was 
carried out in collaboration with the laboratoly of Prof J.P Kamerlrng of the Universit). 
of U w h t ,  Netherlands and the efforts are currently underway to eiucidate the complete 
structure of the Plchza expressed hCG. 
The common L a m  of receptors and antibodies against the l~gand is that both 
d~splay very spec~fic, high affinity bindmg towards the ligand. Hence, it is logical to 
speculate that the antigen binding regions of the antibodies that lnhibtt homone binding 
and/or response, exhibit homology wth d~stinct domains of the receptor. By identiiLing 
the epltopes recogruzed by such ant~bodies, it should be posstble to predict contact Points 
between the hormone and the receptor. In the present study, this hypothesis has been 
tested using monoclonal antibodies (MAbs) against hCC ~ c o g n ~ ~ g  differentepltopes in 
the hormone molecule and having different effects on hormone binding and response 
(Chapter 4). These MAbs were classified as a subunit specific, P subunit specific or 
hetemdimer spelfic dependmg on then ab~lities to bind either subunit in addition to the 
hormone ltseK Interestingly, it was observed that the hCGP subunit specific MAbs- as 
well as, heterodlmer s~eclfic MAbS lnh~blted hCG receptor blndlng and hence the 
response generated by hCG, while the hCGa subunit spec~fic MAbs lnhlbjted only 
response to the hormone wthout lnterfenng In blndlng (Sectlon 4.3 1 ) TO dissect out 
these Interactions further the epltopes recognized b> these mttbodles on ~ C G  molecule 
were determined (Sectlon 4 3 2), slngle cham fragment \anable (ScFv) were genented 
from each of these antlbodles and ~t has shoun that these ScFv retaln the functjonajlt) of 
the onglnai antlbod~ (Section 4 3 3) Further, the amino ac~d sequence of each mtlbod) 
was determined (Sectlon 4 3 4) and finally shown that the ant~gen bindtng domains of 
anbbodles show homology to the distlnct reglons of the LH receptor on sequence 
al~gnments between the two uslng three d~fferent programs (4 3 5 )  The hCGP subunit 
specific  MA^ 52/28' displayed dlst~nct homology \ath the ECD of LH receptor ~shlle the 
a subunit speclfic MAb C 10 showed regons homologous to TMD ofthe receptor and the 
heterod~mer specific MAb E l 2  was found to be slmllar to the hlnge reglon of the 
receptor This clearly lnd~cates that the j3 subunlt of hCG IS In close contact u ~ t h  ECD of 
the receptor whlle the a subunlt makes contacts wth the TMD of receptor. The present 
study thus supports the existtng model of hormone receptor ~nteractions, \shich states that 
the hormone first blnds to the exodomaln of the receptor manly through ~ t s  P subunlt 
whlle the lntegnty of the a subun~t 1s cnt~cal for s~gnallng (24,  2 5 )  Uso. the 
observations made In the present study exh~blt an lnterest~ng poss~blllb of antlgen 
anbbody complexes belng used as surrogate models for galnlng lnslghts Into hormone 
receptor complex 
Further, ~t has been reported that hCG has lmmunocontraceptlve potentlal(26) Actice 
and passive immunization stud~es wth hCG in primates and humans have demonstrated 
the possibll~ty of controlling fertil~ty by the ant~bod~es capable ofneutralizlng hCG. T h ~ s  
forms the basls for female contraceptive vacclne that has undergone Phase I1 chnical 
tnals in India The MAb E l 2  charactenzed In the present study drsplayed highly speclfic 
blndlng to heterodimeric hCG exclusively without showing any cross reactlvltj wth hLH 
(Section 4 3.1)  The epitope mapplng analysls revealed that thls antibody recognizes a 
unique discontinuous ep~tope present only m the heterodimeric hCG and is dlst~nct from 
the unique C-termmal extension ofhCGj3 absent in hLHP (Sect~on 4 3 2) The MAb, IgG 
or its recombinant slngle chain w e n t  vanable (ScFv), lnhlbited response to hCG, but 
not to U H  (4 3 3). Thus, the epitope recognized by this MAb is an ideal candidate 
antigen for mmunocontraceptlon The MAb E l 2  can also be used for Passive 
lmmunlzation In case of emergency contraception. Another potential application of hCG 
speclfic antlbodres 1s In homlng and the treatment of tumors that secrete hCGP subunit 
The hCGP subunit specific MAbs used m the present study 52/12 and 52R8' that 
Inhibited hCG receptor blnding as well as response generated by hCG can be used in 
treating such tumors The funct~onal ScFvs generated from these MAbs In the Present 
study can be made use of on humanization. Thus, the present study has yielded some 
Important molecules for therapeutic applications besides providing a new platform for 
structure-function relationship stud~es of the complex gl~copmteln hormones. 
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